The Discounted Cash Flow (DCF) valuation of Heron Therapeutics Inc (HRTX) is (20.03) USD. With the latest stock price at 1.69 USD, the upside of Heron Therapeutics Inc based on DCF is -1285.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.8% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (51.87) - (12.96) | (20.03) |
| Upside | -3169.5% - -866.7% | -1285.5% |